The DOI matches its Crossref record; 187 of the 187 references it cites were found in a registry or an index.
Cytosolic DNA Sensing in Organismal Tumor Control
Open accessAbstract
Besides constituting a first layer of defense against microbial challenges, the detection of cytosolic DNA is fundamental for mammalian organisms to control malignant transformation and tumor progression. The accumulation of DNA in the cytoplasm can initiate the proliferative inactivation (via cellular senescence) or elimination (via regulated cell death) of neoplastic cell precursors. Moreover, cytosolic DNA sensing is intimately connected to the secretion of cytokines that support innate and adaptive antitumor immunity. Here, we discuss the molecular mechanisms whereby cytosolic DNA enables cell-intrinsic and -extrinsic oncosuppression, and their relevance for the development of novel therapeutic approaches that reinstate anticancer immunosurveillance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Both genomic stress and DDR defects favor the cytosolic accumulation of single-stranded DNA (ssDNA) in support of various oncosuppressive processes, including a cancer-celldependent immunostimulatory response driven by cyclic GMPAMP synthase (CGAS) and stimulator of interferon response cGAMP interactor 1 (STING1; best known as STING) (Vanpouille-Box et al., 2018)”
From Immunomodulation by targeted anticancer agents (2021) · cites this paper as Vanpouille-Box et al., 2018
Citations
Cites
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680
Self-citationA Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491 · cited 1×
“, 2007); and (4) methylation status (Hemmi et al., 2000).”
Elements of cancer immunity and the cancer–immune set point
Chen, D. S., & Mellman, I. (2017) · Nature · doi:10.1038/nature21349 · Cited by 5,352
Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway
Sun, L., Wu, J., Du, F., Chen, X., & Chen, Z. J. (2013) · Science · doi:10.1126/science.1232458 · Cited by 4,996
STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling
Ishikawa, H., & Barber, G. N. (2008) · Nature · doi:10.1038/nature07317 · Cited by 3,576
Immunogenic cell death in cancer and infectious disease
Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L., & Kroemer, G. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2016.107 · Cited by 3,119
Self-citationApetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., et al. (2007) · Nature Medicine · doi:10.1038/nm1622 · Cited by 3,056
Cellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
Type I interferons in infectious disease
McNab, F., Mayer-Barber, K., Sher, A., Wack, A., & O'Garra, A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3787 · Cited by 2,780
Molecular mechanisms of cisplatin resistance
Galluzzi, L., Senovilla, L., Vitale, I., Michels, J., Martins, I., Kepp, O., Castedo, M., & Kroemer, G. (2012) · Oncogene · doi:10.1038/onc.2011.384 · Cited by 2,760
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 251
McGrail, D. J., Pilie, P. G., Dai, H., Lam, T., Liang, Y., Voorwerk, L., Kok, M., Zhang, X. H.-F., Rosen, J. M., Heimberger, A. B., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abe6201 · Cited by 36
Huang, M., Cha, Z., Liu, R., Lin, M., Gafoor, N. A., Kong, T., Ge, F., & Chen, W. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1399926 · Cited by 36
Baba, T., Yoshida, T., Tanabe, Y., Nishimura, T., Morishita, S., Gotoh, N., Hirao, A., Hanayama, R., & Mukaida, N. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03587-x · Cited by 33
Breast Cancer Predisposition Genes and Synthetic Lethality
Neiger, H. E., Siegler, E. L., & Shi, Y. H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115614 · Cited by 33
Abt, E. R., Le, T. M., Dann, A. M., Capri, J. R., Poddar, S., Lok, V. M., Li, L., Liang, K., Creech, A. L., Rashid, K., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110236 · Cited by 33
Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients
Holíček, P., Truxová, I., Raková, J., Šálek, C., Hensler, M., Kovář, M., Reiniš, M., Mikyšková, R., Pasulka, J., Vosahlikova, S., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05728-w · Cited by 31
Self-citationTargeting the DNA replication stress phenotype of KRAS mutant cancer cells
Zubaidi, T. A., Gehrisch, O. H. F., Genois, M., Liu, Q., Lü, S., Kung, J., Xie, Y., Schuemann, J., Lu, H., Hata, A. N., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-83142-y · Cited by 34
Guo, D., Ma, D., Liu, P., Lan, J., Liu, Z., & Liu, Q. (2021) · Aging · doi:10.18632/aging.202740 · Cited by 31
Radiopharmaceuticals as combinatorial partners for immune checkpoint inhibitors
Pouget, J., Chan, T. A.-T., Galluzzi, L., & Constanzo, J. (2023) · Trends in cancer · doi:10.1016/j.trecan.2023.07.014 · Cited by 32
Self-citationHe, J., Yan, Y., Zhang, J., Wei, Z., Li, H., & Xing, L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1298683 · Cited by 31
cGAS‐STING signaling in cancer: Regulation and therapeutic targeting
Fan, X., Song, X., Chen, W., Liang, H., Nakatsukasa, H., & Zhang, D. (2023) · MedComm – Oncology · doi:10.1002/mog2.49 · Cited by 28
Mitochondrial control of innate immune signaling by irradiated cancer cells
Yamazaki, T., & Galluzzi, L. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1797292 · Cited by 31
Self-citationThe role of extracellular DNA (exDNA) in cellular processes
Fernández-Domínguez, I. J., Manzo-Merino, J., Taja‐Chayeb, L., Dueñas‐González, A., Pérez‐Cárdenas, E., & Trejo‐Becerril, C. (2021) · Cancer Biology & Therapy · doi:10.1080/15384047.2021.1890319 · Cited by 28
Crosstalk between cGAS-STING pathway and autophagy in cancer immunity
Lu, Q., Chen, Y., Li, J., Zhu, F., & Zheng, Z. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1139595 · Cited by 28
Korneenko, T. V., Pestov, N. B., Nevzorov, I. A., Daks, A. A., Николаевич, Т. К., Солопова, О. Н., & Barlev, N. A. (2023) · Pharmaceuticals · doi:10.3390/ph16121675 · Cited by 29
CX-5461 Treatment Leads to Cytosolic DNA-Mediated STING Activation in Ovarian Cancer
Cornelison, R., Biswas, K., Llaneza, D. C., Harris, A. R., Sosale, N. G., Lazzara, M. J., & Landen, C. N. (2021) · Cancers · doi:10.3390/cancers13205056 · Cited by 26
Proctor, M. A., Cruz, J. L. G., Daignault, S. M., Veitch, M., Zeng, B., Ehmann, A., Sabdia, M. B., Snell, C. E., Keane, C., Dolcetti, R., et al. (2021) · Cancers · doi:10.3390/cancers13153733 · Cited by 25
Chen, X., Wang, L., Cao, L., Li, T., Li, Z., Sun, Y., Ding, J., Zhou, C., Xie, Y., Yue, N., et al. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2000989 · Cited by 24
Immunogenic Cell Death Driven by Radiation—Impact on the Tumor Microenvironment
Yamazaki, T., Vanpouille‐Box, C., Demaria, S., & Galluzzi, L. (2020) · Cancer treatment and research · doi:10.1007/978-3-030-38862-1_10 · Cited by 28
Self-citationSong, X., Aw, J. T. M., Ma, F., Cheung, M. F., Leung, D., & Herrup, K. (2021) · The Journal of Neuroscience · doi:10.1523/jneurosci.0845-21.2021 · Cited by 23
Cellular Discrepancy of Platinum Complexes in Interfering with Mitochondrial DNA
Jin, S., He, Y., Feng, C., Yuan, J., Guo, Y., Guo, Z., & Wang, X. (2025) · ACS Central Science · doi:10.1021/acscentsci.4c01941 · Cited by 23
Martino, M. D., Tkach, M., Bruni, S., Rocha, D., Mercogliano, M. F., Cenciarini, M. E., Chervo, M. F., Proietti, C. J., Dingli, F., Loew, D., et al. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1715767 · Cited by 23
Mechanistic rationales for combining immunotherapy with radiotherapy
Chi, A., & Nguyen, N. P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1125905 · Cited by 25
Context-dependent impact of type I interferon signaling in cancer
Ruiz-Iglesias, A., Guilbaud, E., Galluzzi, L., & Mañes, S. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02495-4 · Cited by 25
Self-citationThe Killer’s Web: Interconnection between Inflammation, Epigenetics and Nutrition in Cancer
Mecca, M., Picerno, S., & Cortellino, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052750 · Cited by 24
Jesenko, T., Bošnjak, M., Markelc, B., Serša, G., Žnidar, K., Heller, L. C., & Čemažar, M. (2020) · Cancers · doi:10.3390/cancers12113365 · Cited by 22
Impact of radiation therapy on the immunological tumor microenvironment
Guilbaud, E., Naulin, F., Meziani, L., Deutsch, É., & Galluzzi, L. (2025) · Cell chemical biology · doi:10.1016/j.chembiol.2025.04.001 · Cited by 25
Self-citationG�rard, M., Chatelain, C., Delaunay, T., Tostivint, E. P., Bennouna, J., & Fonteneau, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.695770 · Cited by 25
Immunogenic cell death-inducing metal complexes: From the benchtop to the clinic
Sen, S., Karoscik, K., Maier, E. Y., & Arambula, J. F. (2023) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2023.102277 · Cited by 23
Biomaterial-enabled therapeutic modulation of cGAS-STING signaling for enhancing antitumor immunity
Liu, Y., Yang, F., Wang, X., Yang, B., Li, M., & Luo, Z. Y. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.03.026 · Cited by 24
Liang, K., Abt, E. R., Le, T. M., Cho, A. E.-H., Dann, A. M., Cui, J., Li, L., Rashid, K., Creech, A. L., Liu, W., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2105390118 · Cited by 20
Plavc, G., & Strojan, P. (2020) · Radiology and Oncology · doi:10.2478/raon-2020-0060 · Cited by 20
Verrier, E. R., & Langevin, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.637399 · Cited by 18
A Link between Replicative Stress, Lamin Proteins, and Inflammation
Willaume, S., Rass, E., Fontanilla-Ramirez, P., Moussa, A., Wanschoor, P., & Bertrand, P. (2021) · Genes · doi:10.3390/genes12040552 · Cited by 28
Stress-induced cellular senescence contributes to chronic inflammation and cancer progression.
KOBASHIGAWA, S., M. SAKAGUCHI, Y., MASUNAGA, S., & MORI, E. (2019) · Thermal Medicine · doi:10.3191/thermalmed.35.41 · Cited by 18
Xue, Y., Wang, Y., Ren, Z., & Yu, K. (2024) · Oncogene · doi:10.1038/s41388-024-03248-1 · Cited by 20
Immunological signatures from irradiated cancer-associated fibroblasts
Berzaghi, R., Gundersen, K., Pedersen, B. D., Utne, A., Yang, N., Hellevik, T., & Martínez-Zubiaurre, I. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1433237 · Cited by 22
Targeting protein kinases benefits cancer immunotherapy
Zhang, Z., Bu, L., Luo, J., & Guo, J. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188738 · Cited by 18
Ge, Y., Bao, Y., Shao, A., Jin, K., Mao, Z., Tong, W., & Ye, J. (2024) · Nano Today · doi:10.1016/j.nantod.2024.102391 · Cited by 17
Immunotherapies for locally aggressive cancers
Adams, S. C., Nambiar, A., Bressler, E. M., Raut, C. P., Colson, Y. L., Wong, W. W., & Grinstaff, M. W. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115331 · Cited by 15
The microbiota in radiotherapy-induced cancer immunosurveillance
Chen, J., Deutsch, É., Kroemer, G., Galluzzi, L., & Zitvogel, L. (2025) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-025-01052-8 · Cited by 18
Self-citationMitotic SENP3 activation couples with cGAS signaling in tumor cells to stimulate anti-tumor immunity
Hu, G., Chen, Y., Yang, X., Wang, Y., He, J., Wang, T., Fan, Q., Deng, L., Tu, J., Tan, H., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05063-6 · Cited by 14
Ghukasyan, R., Liang, K., Chau, K., Li, L., Chan, C., Abt, E. R., Le, T. M., Park, J. Y., Wu, N., Premji, A., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-3322 · Cited by 14
Bonassi, S., & Fenech, M. F. (2019) · Royal Society of Chemistry eBooks · doi:10.1039/9781788013604-00038 · Cited by 15
Immuno-epigenetic escape of cancer stem cells
Galluzzi, L., & Kroemer, G. (2022) · Nature Immunology · doi:10.1038/s41590-022-01293-0 · Cited by 14
Self-citationHelm, A., Totis, C., Durante, M., & Fournier, C. (2023) · International review of cytology · doi:10.1016/bs.ircmb.2023.01.001 · Cited by 13
Targeting Cancer Stem Cells through Epigenetic Modulation of Interferon Response
Huang, J.-L., Chen, S., & Lin, C. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12040556 · Cited by 13
He, K.-Y., Zhao, A., Guo, J.-R., Wu, D., Liu, H., Gao, F., Liu, M., Yang, J.-Y., Lei, X., Li, J.-Q., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60221-6 · Cited by 13
Nakajima, S., Kaneta, A., Okayama, H., Saito, K., Kikuchi, T., Endo, E., Matsumoto, T., Fukai, S., Sakuma, M., Sato, T., et al. (2023) · Cancers · doi:10.3390/cancers15102826 · Cited by 12
Ku70 senses cytosolic DNA and assembles a tumor-suppressive signalosome
Pandey, A., Shen, C. X., Feng, S., Tuipulotu, D. E., Ngo, C., Liu, C., Kurera, M., Mathur, A., Venkataraman, S., Zhang, J., et al. (2024) · Science Advances · doi:10.1126/sciadv.adh3409 · Cited by 12
Detection and quantification of cytosolic DNA
Spada, S., Yamazaki, T., & Vanpouille‐Box, C. (2019) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2019.07.042 · Cited by 13
Self-citationChen, X., Yang, M., Wang, L., Wang, Y., Tu, J., Zhou, X., & Yuan, X. (2023) · BMC Cancer · doi:10.1186/s12885-023-10850-1 · Cited by 12
A pyrophosphatase-coupled assay to monitor the NTase activity of cGAS
Hooy, R. M., & Sohn, J. (2019) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2019.06.005 · Cited by 10
Activation of RIG-I signaling to increase the pro-inflammatory phenotype of a tumor
Elion, D. L., & Cook, R. S. (2019) · Oncotarget · doi:10.18632/oncotarget.26729 · Cited by 12
Pouget, J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822960-6.00137-x · Cited by 13
Huang, S., Xie, P., Huang, X., Chen, Z., Yang, J., Wang, J., Liu, C., Li, H., & Zhou, B. (2023) · PubMed Central · Cited by 11
Ellerin, B. E., Demandante, C. G. N., & Martins, J. T. (2020) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2020.01.001 · Cited by 10
Wang, X., Zhan, Z., Wang, Z., Zhang, Y., Zhao, K., Han, L., Zhou, X., Guo, Y., Fan, F., Ding, J., et al. (2024) · MedComm · doi:10.1002/mco2.70001 · Cited by 10
Marinković, E., Chen, M., Schubert, N., Dar, E. D., Poth, T., Leung, J. Y., Lohre, J., Sahni, J. M., Tun, C., Rajeswaran, P., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-2262 · Cited by 11
Zhou, Y., Guo, Y., & Wang, Y. (2022) · IET Systems Biology · doi:10.1049/syb2.12041 · Cited by 10
Kashefizadeh, A., & Kazemizadeh, H. (2022) · Clinical & Translational Oncology · doi:10.1007/s12094-022-02949-x · Cited by 10
Galluzzi, L., & Kroemer, G. (2019) · Trends in Cell Biology · doi:10.1016/j.tcb.2019.03.005 · Cited by 10
Self-citationLin, W., Chen, W., Zhong, J., Ueki, H., Xu, A., Watanabe, M., Araki, M., Liu, C., Nasu, Y., & Huang, P. (2022) · Journal of Cancer · doi:10.7150/jca.66922 · Cited by 10
Wang, H., Zhang, Y., Tian, Y., Yang, W., Wang, Y., Hou, H., Pan, H., Pei, S., Zhu, H., Gu, Z., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-0744 · Cited by 9
Adaptive inhibition of CGAS signaling by TREX1
Lira, M. C., Vanpouille‐Box, C., & Galluzzi, L. (2024) · Trends in cancer · doi:10.1016/j.trecan.2024.02.001 · Cited by 9
Self-citationFan, Y., Dong, Z., Wu, Y., & Wen, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1692365 · Cited by 10
Methods to Detect Immunogenic Cell Death In Vivo
Yamazaki, T., Buqué, A., Rybstein, M. D., Chen, J., Sato, A., & Galluzzi, L. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9773-2_20 · Cited by 9
Self-citationFennell, D. A., & Dulloo, S. (2021) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2021.08.004 · Cited by 9
Mosley, S. R., Chen, A., Doell, D. N. W., Choi, S., Mowat, C., Meier‐Stephenson, F., Meier‐Stephenson, V., & Baker, K. (2025) · Cell Reports · doi:10.1016/j.celrep.2024.115177 · Cited by 9
Ridnour, L. A., Cheng, R. Y. S., Kedei, N., Somasundaram, V., Bhattacharyya, D. D., Basudhar, D., Wink, A. L., Walke, A. J., Kim, C., Heinz, W. F., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.165356 · Cited by 11
A novel melanin complex displayed the affinity to HepG2 cell membrane and nucleus
Xin, C., Cheng, C., Hou, K., Bao, M., Zhang, H., & Wang, Z. (2021) · Materials Science and Engineering C · doi:10.1016/j.msec.2021.111923 · Cited by 8
Using epigenetic modifiers to target cancer stem cell immunoevasion
Galassi, C., Vitale, I., & Galluzzi, L. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.11.003 · Cited by 8
Self-citationDevelopment of a risk model to predict prognosis in breast cancer based on cGAS-STING-related genes
Chen, C., Wang, J., Dong, C., LIM, D. J., & Feng, Z. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1121018 · Cited by 8
PARP7 and nucleic acid-driven oncosuppression
Naulin, F., Guilbaud, E., & Galluzzi, L. (2024) · Cellular and Molecular Immunology · doi:10.1038/s41423-024-01182-6 · Cited by 7
Self-citationPerini, T., Zordan, P., Pizzo, R. D., Resnati, M., Viviani, L., Stefanoni, D., Cassina, L., Orfanelli, U., Trudu, M., Oliva, L., et al. (2025) · Blood · doi:10.1182/blood.2024026340 · Cited by 6
Molecular mechanisms of immune cell death in immunosenescence
Verduijn, J., Coutant, K., Fane, M. E., & Galluzzi, L. (2025) · Cell Death and Differentiation · doi:10.1038/s41418-025-01535-2 · Cited by 9
Self-citationChromosomal instability drives immunosuppression and metastatic dissemination
Vitale, I., Galassi, C., & Galluzzi, L. (2023) · Cell Research · doi:10.1038/s41422-023-00876-2 · Cited by 6
Self-citationZhao, Q., Su, X., Xue, J., Liu, Y., Zhu, J., Cai, X., & Qin, S. (2024) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-024-03769-4 · Cited by 8
Harnessing Genomic Stress for Antitumor Immunity
Pu, C., Tao, S., Xu, J., & Huang, M. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8221 · Cited by 6
Poly(I:C), a double stranded RNA analog, activates the anti-viral DNA sensors in buffalo fibroblasts
Chera, J. S., Kumar, S., Bairagi, A. K., Kumar, A., Chandra, P., Vats, A., Ali, M., Roshan, M., Kataria, R. S., & De, S. (2023) · Veterinary Vaccine · doi:10.1016/j.vetvac.2023.100016 · Cited by 6
Lin, H., Pang, W.-P., Yuan, H., Kong, Y., Long, F., Zhang, R., Yang, L., Fang, Q.-L., Pan, A., Fan, X., et al. (2023) · Aging · doi:10.18632/aging.204870 · Cited by 5
EGFR blockade activates interferon
Yoshida, R., & Barbie, D. A. (2020) · Nature Cancer · doi:10.1038/s43018-020-0055-1 · Cited by 6
Preface: Endoplasmic reticulum in health and disease
Kepp, O., & Galluzzi, L. (2020) · International review of cytology · doi:10.1016/s1937-6448(20)30020-4 · Cited by 6
Self-citationYang, G., Deng-gao, W., Zhao, X., Hao, D., Zhang, Z.-Q., & Liu, D. (2025) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2025.101542 · Cited by 6
MRE11 mobilizes CGAS and drives ZBP1-dependent necroptosis
Beltrán‐Visiedo, M., Balachandran, S., & Galluzzi, L. (2024) · Cell Research · doi:10.1038/s41422-024-00939-y · Cited by 6
Self-citationCao, L., Huang, G., Fan, J., Liu, X., & Ma, Z. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1458884 · Cited by 5
Wang, Y., Fan, N., Wang, R., Li, X., Zhao, F., Miao, L., Wang, X., Yan, X., Zhang, Z., Wu, X., et al. (2025) · ACS Nano · doi:10.1021/acsnano.5c01732 · Cited by 5
Nucleic Acid Sensing at the Interface Between Innate and Adaptive Immunity
Vanpouille‐Box, C., & Galluzzi, L. (2019) · International review of cytology · doi:10.1016/s1937-6448(19)30030-9 · Cited by 5
Self-citationTargeting immune checkpoint therapy: The role of manganese in tumor immunotherapy
Lyu, X., Li, B., & Lin, Z. (2025) · Cancer Pathogenesis and Therapy · doi:10.1016/j.cpt.2025.10.001 · Cited by 4
Sinha, D., Moseley, P., Lu, X., Wright, Q., Gabrielli, B. G., Frazer, I. H., & Cruz, J. L. G. (2022) · Cancers · doi:10.3390/cancers14246150 · Cited by 4
Tayeb, F. J. (2024) · Exploration of Medicine · doi:10.37349/emed.2024.00223 · Cited by 5
Innate immunity in tumour immunoediting and immunosurveillance
Zhang, Z., Zhang, Y., & Lieberman, J. (2025) · The EMBO Journal · doi:10.1038/s44318-025-00650-7 · Cited by 4
Mosley, S. R., Lapa, N., Namdar, A., Catley, T. E., Meier‐Stephenson, F., Mowat, C., Gao, P., Sun, X., Meier‐Stephenson, V., Pyne, A. L. B., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117012 · Cited by 4
He, J., Huang, R., Zong, C., Li, Q., Wang, Y., Zheng, G., Wang, Y., Yang, X., Fang, Y., Fang, F., et al. (2025) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-24-0405 · Cited by 3
Santis, I. D., Zanoni, M., Pignatta, S., Longobardi, P., Tesei, A., & Bevilacqua, A. (2022) · Molecular Imaging and Biology · doi:10.1007/s11307-022-01778-2 · Cited by 3
Quantification of beta-galactosidase activity as a marker of radiation-driven cellular senescence
Klapp, V., Bloy, N., Petroni, G., & Martino, M. D. (2022) · Methods in cell biology · doi:10.1016/bs.mcb.2022.10.001 · Cited by 3
Preface: Life through death—Key role of cellular suicide for colonial and organismal homeostasis
Spetz, J. K. E., & Galluzzi, L. (2020) · International review of cytology · doi:10.1016/s1937-6448(20)30047-2 · Cited by 3
Self-citationDevelopment of therapeutic cancer vaccines based on cancer immunity cycle
Zhang, J., Zheng, Y., Xu, L., Gao, J., Ou, Z., Zhu, M., & Wang, W. (2025) · Frontiers of Medicine · doi:10.1007/s11684-025-1134-6 · Cited by 2
Tobin, E. E., Sharma, A., Kros, S. T., Jima, D. D., Gray, S., & Hall, J. R. (2025) · Frontiers in Cell Death · doi:10.3389/fceld.2025.1658598 · Cited by 2
Sato, A., Bloy, N., Galassi, C., Jiménez‐Cortegana, C., Klapp, V., Aretz, A., Guilbaud, E., Yamazaki, T., Petroni, G., Galluzzi, L., et al. (2022) · Methods in cell biology · doi:10.1016/bs.mcb.2022.05.004 · Cited by 2
Self-citation
Metadata
- Authors
- Vanpouille-Box, C., Demaria, S., Formenti, S. C., & Galluzzi, L.
- Affiliations
- Weill Cornell Medicine (US)
- Corresponding author
- Galluzzi, Lorenzo
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2018-09
- Volume
- 34
- Issue
- 3
- Pages
- 361-378
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2811281203
- Cited by
- 250
- References
- 187
- Citations by year
- 2026: 9 · 2025: 26 · 2024: 30 · 2023: 39 · 2022: 32 · 2021: 36 · 2020: 34 · 2019: 43 · 2018: 1
- FWCI
- 2.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Anna-Maria and Stephen Kellen Foundation
- NIH (R01 CA201246, R01 CA198533)
- The Chemotherapy Foundation
- Breast Cancer Research Foundation
- Weill Cornell Medical College
- Phosplatin Therapeutics
- Sotio a.s.
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- cytosolic DNA sensing, tumor control, cellular senescence, regulated cell death, antitumor immunity, cytokine production, oncosuppression, tumor surveillance, innate immunity, malignant transformation, tumor progression
- MeSH terms
- Animals, Cell Transformation, Neoplastic, Cytosol, DNA, Humans, Immunologic Surveillance, Neoplasms, Cellular Senescence, Apoptosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review